Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 1294 entries
View as:

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

Phase: N/A Priority: Normal
NCT ID: NCT00184717 Org: User:
Start: 08/18/04 End: 12/28/09 Due: 12/28/10

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Phase: N/A Priority: Normal
NCT ID: NCT01580605 Org: User:
Start: 07/17/03 End: 11/28/11 Due: 11/28/12

Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

Phase: N/A Priority: Normal
NCT ID: NCT00806897 Org: User:
Start: 01/31/09 End: 12/31/09 Due: 12/31/10

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01234545 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

Phase: N/A Priority: Normal
NCT ID: NCT01365507 Org: User:
Start: 06/30/11 End: 04/30/12 Due: 04/30/13

A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01682902 Org: User:
Start: 09/30/12 End: 03/31/13 Due: 03/31/14

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02054897 Org: User:
Start: 02/03/14 End: 05/08/15 Due: 05/08/16

A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week

Phase: N/A Priority: Normal
NCT ID: NCT03766854 Org: User:
Start: 12/07/18 End: 12/09/19 Due: 12/09/20

Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00951405 Org: User:
Start: 09/01/09 End: 03/29/11 Due: 03/29/12

Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01427920 Org: User:
Start: 09/30/11 End: 07/31/12 Due: 07/31/13

Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01862367 Org: User:
Start: 05/17/13 End: 06/26/19 Due: 06/26/20

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

Phase: N/A Priority: Normal
NCT ID: NCT02648217 Org: User:
Start: 01/04/16 End: 09/05/16 Due: 09/05/17

A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02033239 Org: User:
Start: 01/31/14 End: 06/30/14 Due: 06/30/15

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01527539 Org: User:
Start: 11/23/01 End: 10/12/04 Due: 10/12/05

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01704378 Org: User:
Start: 04/18/01 End: 03/14/03 Due: 03/14/04

A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02773381 Org: User:
Start: 06/02/16 End: 10/19/18 Due: 10/19/19

First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01208506 Org: User:
Start: 09/30/10 End: 02/29/12 Due: 02/28/13

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01617434 Org: User:
Start: 09/30/12 End: 10/31/13 Due: 10/31/14

Initiation of Insulin Aspart in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00572806 Org: User:
Start: 02/05/03 End: 02/02/04 Due: 02/02/05

Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00818064 Org: User:
Start: 12/31/08 End: 01/31/10 Due: 01/31/11

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01542060 Org: User:
Start: 01/31/04 End: 12/31/04 Due: 12/31/05

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.

Phase: N/A Priority: Normal
NCT ID: NCT03212131 Org: User:
Start: 08/16/17 End: 03/08/18 Due: 03/08/19

A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

Phase: N/A Priority: Normal
NCT ID: NCT06461039 Org: User:
Start: 06/14/24 End: 04/04/25 Due: 04/04/26

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

Phase: N/A Priority: Normal
NCT ID: NCT05894876 Org: User:
Start: 04/29/24 End: 12/31/25 Due: 12/31/26

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Phase: N/A Priority: Normal
NCT ID: NCT02298192 Org: User:
Start: 11/21/14 End: 12/23/15 Due: 12/23/16